Busch Andreas 4
4 · Cyclerion Therapeutics, Inc. · Filed Dec 10, 2021
Insider Transaction Report
Form 4
Busch Andreas
Chief Innovation Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2021-12-09+75,000→ 75,000 totalExercise: $1.93Exp: 2031-12-09→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 2.08333% of the shares of Common Stock on each monthly anniversary of December 9, 2021.